The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis
Open accessAbstract
Importance: An American Academy of Orthopaedic Surgeons guideline recommends tramadol for patients with knee osteoarthritis, and an American College of Rheumatology guideline conditionally recommends tramadol as first-line therapy for patients with knee osteoarthritis, along with nonsteroidal anti-inflammatory drugs. Objective: To examine the association of tramadol prescription with all-cause mortality among patients with osteoarthritis. Design, Setting, and Participants: Sequential, propensity score-matched cohort study at a general practice in the United Kingdom. Individuals aged at least 50 years with a diagnosis of osteoarthritis in the Health Improvement Network database from January 2000 to December 2015, with follow-up to December 2016. Exposures: Initial prescription of tramadol (n = 44 451), naproxen (n = 12 397), diclofenac (n = 6512), celecoxib (n = 5674), etoricoxib (n = 2946), or codeine (n = 16 922). Main Outcomes and Measures: All-cause mortality within 1 year after initial tramadol prescription, compared with 5 other pain relief medications. Results: After propensity score matching, 88 902 patients were included (mean [SD] age, 70.1 [9.5] years; 61.2% were women). During the 1-year follow-up, 278 deaths (23.5/1000 person-years) occurred in the tramadol cohort and 164 (13.8/1000 person-years) occurred in the naproxen cohort (rate difference, 9.7 deaths/1000 person-years [95% CI, 6.3-13.2]; hazard ratio [HR], 1.71 [95% CI, 1.41-2.07]), and mortality was higher for tramadol compared with diclofenac (36.2/1000 vs 19.2/1000 person-years; HR, 1.88 [95% CI, 1.51-2.35]). Tramadol was also associated with a higher all-cause mortality rate compared with celecoxib (31.2/1000 vs 18.4/1000 person-years; HR, 1.70 [95% CI, 1.33-2.17]) and etoricoxib (25.7/1000 vs 12.8/1000 person-years; HR, 2.04 [95% CI, 1.37-3.03]). No statistically significant difference in all-cause mortality was observed between tramadol and codeine (32.2/1000 vs 34.6/1000 person-years; HR, 0.94 [95% CI, 0.83-1.05]). Conclusions and Relevance: Among patients aged 50 years and older with osteoarthritis, initial prescription of tramadol was associated with a significantly higher rate of mortality over 1 year of follow-up compared with commonly prescribed nonsteroidal anti-inflammatory drugs, but not compared with codeine. However, these findings may be susceptible to confounding by indication, and further research is needed to determine if this association is causal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
OARSI guidelines for the non-surgical management of knee osteoarthritis
McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. M., Hawker, G. A., Henrotin, Y., Hunter, D. J., Kawaguchi, H., et al. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.01.003 · Cited by 3,110
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Checking the Cox model with cumulative sums of martingale-based residuals
LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432
Trends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,137
Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd Edition
Jevsevar, D. S. (2013) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-201309020-00008 · Cited by 634
Sturmer, T., Rothman, K. J., Avorn, J., & Glynn, R. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq198 · Cited by 446
The Comparative Safety of Analgesics in Older Adults With Arthritis
Solomon, D. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.391 · Cited by 416
Prescription of long-acting opioids and mortality in patients with chronic noncancer pain
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2016) · JAMA · doi:10.1001/jama.2016.7789 · Cited by 369
Smith, S. R., Deshpande, B. R., Collins, J. E., Katz, J. N., & Losina, E. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.01.135 · Cited by 256
The Comparative Safety of Opioids for Nonmalignant Pain in Older Adults
Solomon, D. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.450 · Cited by 253
Fracture risk associated with the use of morphine and opiates
VESTERGAARD, P., REJNMARK, L., & MOSEKILDE, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01667.x · Cited by 244
Brouquet, A., Cudennec, T., Benoist, S., Moulias, S., Beauchet, A., Penna, C., Teillet, L., & Nordlinger, B. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c1cfc9 · Cited by 236
For the International NSAID Consensus Group, Scarpignato, C., Lanas, A., Blandizzi, C., Lems, W. F., Hermann, M., & Hunt, R. H. (2015) · BMC Medicine · doi:10.1186/s12916-015-0285-8 · Cited by 236
An application of propensity score matching using claims data
Seeger, J. D., Williams, P. L., & Walker, A. M. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1062 · Cited by 218
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Hicks, B. M., Filion, K. B., Yin, H., Sakr, L., Udell, J. A., & Azoulay, L. (2018) · BMJ · doi:10.1136/bmj.k4209 · Cited by 207
Trends in Prescription of Opioids From 2003–2009 in Persons With Knee Osteoarthritis
Wright, E. A., Katz, J. N., Abrams, S. K., Solomon, D. H., & Losina, E. (2014) · Arthritis Care & Research · doi:10.1002/acr.22360 · Cited by 164
Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures
Hassamal, S., Miotto, K. A., Dale, W., & Danovitch, I. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.04.025 · Cited by 151
Pharmacoepidemiology and Drug Safety
Boshier, A., Shakir, S. A. W., Telfer, P. T., Behr, E., Pakrashi, T., & Camm, A. J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(issn)1099-1557 · Cited by 136
Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients
Kimmel, P. L., Fwu, C., Abbott, K. C., Eggers, A. W., Kline, P. P., & Eggers, P. W. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010098 · Cited by 126
Burr, N. E., Smith, C., West, R. M., Hull, M. A., & Subramanian, V. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.10.022 · Cited by 114
Latimer, N. R., Lord, J. L., Grant, R. L., O’Mahony, R., Dickson, J., & Conaghan, P. G. (2009) · BMJ · doi:10.1136/bmj.b2538 · Cited by 113
Tramadol Use and the Risk of Hospitalization for Hypoglycemia in Patients With Noncancer Pain
Fournier, J., Azoulay, L., Yin, H., Montastruc, J., & Suissa, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6512 · Cited by 112
Fatal unintentional intoxications with tramadol during 1995–2005
Tjäderborn, M., Jönsson, A. K., Hägg, S., & Ahlner, J. (2007) · Forensic Science International · doi:10.1016/j.forsciint.2007.02.007 · Cited by 107
Comparison of fatal poisonings by prescription opioids
Häkkinen, M., Launiainen, T., Vuori, E., & Ojanperä, I. A. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.07.011 · Cited by 95
Tramadol deaths in Northern Ireland: A review of cases from 1996 to 2012
Randall, C., & Crane, J. (2014) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2014.01.006 · Cited by 93
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis
Ogdie, A., Maliha, S. G., Shin, D. B., Löve, Þ. J., Baker, J. F., Jiang, Y., Choi, H. K., & Gelfand, J. M. (2017) · Rheumatology · doi:10.1093/rheumatology/kew502 · Cited by 87
Self-citationKatz, J. N., Smith, S. R., Collins, J. E., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G., Yelin, E., Paltiel, A. D., & Losina, E. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.10.006 · Cited by 83
Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011
Handley, S. A., & Flanagan, R. J. (2014) · Clinical Toxicology · doi:10.3109/15563650.2013.872791 · Cited by 80
Medication fall risk in old hospitalized patients: A retrospective study
Costa-Dias, M., Oliveira, A. S., Martins, T. V., Araújo, F., Santos, A. S., Moreira, C. N., & JOSÉ, H. M. G. (2013) · Nurse Education Today · doi:10.1016/j.nedt.2013.05.016 · Cited by 62
Polypharmacy and adverse outcomes after hip fracture surgery
Härstedt, M., Rogmark, C., Sutton, R., Melander, O., & Fedorowski, A. (2016) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-016-0486-7 · Cited by 60
Chen, T., Chen, L., & Knaggs, R. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4320 · Cited by 58
Tramadol for noncancer pain and the risk of hyponatremia
Fournier, J.-P., Yin, H., Nessim, S. J., Montastruc, J.-L., & Azoulay, L. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.046 · Cited by 41
Cited by
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 1,965
Sharma, L. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp1903768 · Cited by 1,073
Osteoarthritis year in review 2019: epidemiology and therapy
Kloppenburg, M., & Berenbaum, F. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.01.002 · Cited by 532
Emerging pharmaceutical therapies for osteoarthritis
Latourte, A., Kloppenburg, M., & Richette, P. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00518-6 · Cited by 418
Metadata
- Authors
- Zeng, C., Dubreuil, M., LaRochelle, M. R., Lu, N., Wei, J., Choi, H. K., Lei, G., & Zhang, Y.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-03-12
- Volume
- 321
- Issue
- 10
- Pages
- 969
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2921856072
- Cited by
- 256
- References
- 35
- FWCI
- 34.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.